Medical Oncologists’ Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care | Zendy

Stacy W. Gray | Zendy; Benjamin Kim | Zendy; Lynette M. Sholl | Zendy; Angel M. Cronin | Zendy; Aparna R. Parikh | Zendy; Carrie N. Klabunde | Zendy; Katherine L. Kahn | Zendy; David A. Haggstrom | Zendy; Nancy L. Keating | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Medical Oncologists’ Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care

Author(s) -

Stacy W. Gray,

Benjamin Kim,

Lynette M. Sholl,

Angel M. Cronin,

Aparna R. Parikh,

Carrie N. Klabunde,

Katherine L. Kahn,

David A. Haggstrom,

Nancy L. Keating

Publication year - 2017

Publication title -

journal of oncology practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.555

H-Index - 60

eISSN - 1935-469X

pISSN - 1554-7477

DOI - 10.1200/jop.2016.016659

Subject(s) - medicine , kras , guideline , colorectal cancer , lynch syndrome , oncology , lung cancer , microsatellite instability , family medicine , genetic testing , cancer , test (biology) , medline , specialty , pathology , dna mismatch repair , chemistry , paleontology , allele , biochemistry , biology , political science , law , microsatellite , gene

Genomic testing improves outcomes for many at-risk individuals and patients with cancer; however, little is known about how genomic testing for non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC) is used in clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research